Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1228 ARTÍCULOS , VIENDO DEL 76 AL 90

Recent progress on the role of GABAergic neurotransmission in the pathogenesis of Alzheimer's disease

Abbas G, Mahmood W, Kabir N.

Rev Neurosci. 2016 Jun 1;27(4):449-55. doi: 10.1515/revneuro-2015-0062.

Recent approaches and challenges in iPSCs: modeling and cell-based therapy of Alzheimer's disease

Csöbönyeiová M, Polák Š, Danišovič L.

Rev Neurosci. 2016 Jul 1;27(5):457-64. doi: 10.1515/revneuro-2015-0054.

Alzheimer's disease: Targeting the Cholinergic System

Ferreira-Vieira TH, Guimaraes IM, Silva FR, Ribeiro FM.

Curr Neuropharmacol. 2016;14(1):101-15. doi: 10.2174/1570159x13666150716165726.

[Immunotherapy for Alzheimer's disease]

Falkentoft AC, Hasselbalch SG.

Ugeskr Laeger. 2016 Jan 18;178(3):V07150588.

Microtubule-Tau Interaction as a Therapeutic Target for Alzheimer's Disease

Pachima YI, Zhou LY, Lei P, Gozes I.

J Mol Neurosci. 2016 Feb;58(2):145-52. doi: 10.1007/s12031-016-0715-x.

The Role of α7 Nicotinic Acetylcholine Receptors and α7-Specific Antibodies in Neuroinflammation Related to Alzheimer Disease

Skok M, Lykhmus O.

Curr Pharm Des. 2016;22(14):2035-49. doi: 10.2174/1381612822666160127112914.

Tau-directed approaches for the treatment of Alzheimer's disease: focus on leuco-methylthioninium

Seripa D, Solfrizzi V, Imbimbo BP, Daniele A, Santamato A, Lozupone M, Zuliani G, Greco A, Logroscino G, Panza F.

Expert Rev Neurother. 2016;16(3):259-77. doi: 10.1586/14737175.2016.1140039.

Glial Cells - The Key Elements of Alzheimer´s Disease

Dzamba D, Harantova L, Butenko O, Anderova M.

Curr Alzheimer Res. 2016;13(8):894-911. doi: 10.2174/1567205013666160129095924.

Probabilistic Cost-Effectiveness Analysis of Vaccination for Mild or Moderate Alzheimer's Disease

Yang KC, Chen HH.

Curr Alzheimer Res. 2016;13(7):809-16. doi: 10.2174/1567205013666160129095012.

[MECHANISMS OF NEURONAL LOSS IN ALZHEIMER''S DISEASE]

Mukhin VN, Pavlov KI, Klimenko VM.

Ross Fiziol Zh Im I M Sechenova. 2016 Feb;102(2):113-29.

Brain atrophy in Alzheimer's Disease and aging

Pini L, Pievani M, Bocchetta M, Altomare D, Bosco P, Cavedo E, Galluzzi S, Marizzoni M, Frisoni GB.

Ageing Res Rev. 2016 Sep;30:25-48. doi: 10.1016/j.arr.2016.01.002. Epub 2016 Jan 28.

BACE1 Physiological Functions May Limit Its Use as Therapeutic Target for Alzheimer's Disease

Barão S, Moechars D, Lichtenthaler SF, De Strooper B.

Trends Neurosci. 2016 Mar;39(3):158-169. doi: 10.1016/j.tins.2016.01.003. Epub 2016 Jan 30.

Three-Dimensional Eigenbrain for the Detection of Subjects and Brain Regions Related with Alzheimer's Disease

Zhang Y, Wang S, Phillips P, Yang J, Yuan TF.

J Alzheimers Dis. 2016;50(4):1163-79. doi: 10.3233/JAD-150988.

Fish Consumption, Brain Mercury, and Neuropathology in Patients With Alzheimer Disease and Dementia

Kröger E, Laforce R Jr.

JAMA. 2016 Feb 2;315(5):465-6. doi: 10.1001/jama.2016.0005.

Gene Therapy Strategies for Alzheimer's Disease: An Overview

Alves S, Fol R, Cartier N.

Hum Gene Ther. 2016 Feb;27(2):100-7. doi: 10.1089/hum.2016.017.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias